Ambu CEO: Strong US dollar revenue boost will continue
Like many other exporting companies, the Danish medtech company has been enjoying a currency tailwind in the US – and the forecast says the effect will continue, according to CEO Britt Meelby Jensen.
by marketwire, translated by daniel pedersen
Half of Ambu’s revenue is being generated in the US, and has recently been boosted by a strong US dollar – an effect that won’t stop anytime soon, according to the medtech company’s chief executive, Britt Meelby Jensen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu's Q3 endoscope sales went up 4%
For subscribers
